Ali Aminian, ESC 2021 – Obesity and COVID-19
Access all of the content
Dr Ali Aminian (Director, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH, USA) kindly shared his thoughts on the association between obesity and COVID-19 and the results of his study on the association of prior metabolic surgery and bariatric surgery with COVID-19 severity from the virtual ESC Congress 2021.
- What have we learned about the association between obesity and COVID-19 outcomes? (0.18)
- Could you tell us a little about your study investigating the association of prior metabolic surgery and bariatric surgery with COVID-19 severity? (1.00)
- What were the methods of the study? (1.43)
- What were your findings? (3.40)
- What were the limitations of this study? (6.00)
- What future studies are ongoing or planned? (6.48)
Speaker disclosures: Dr Ali Aminian has received research support from Medtronic.
Support: Interview and filming supported by Touch Medical Media and conducted by Heather Hall.
Filmed during a remote video call with Dr Ali Aminian as a highlight of ESC 2021, August 2021.
Share this Video
Related Videos In COVID-19
Caroline Sindet-Pedersen, ESC 2022: SARS-CoV-2 mRNA vaccines in patients with heart failure
Studies investigating the safety and efficacy of the severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) mRNA vaccines lacked representation of patients with heart failure. In this touchCARDIO interview, we speak with Dr Caroline Sindet-Pedersen (Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark) to discuss the study presented at ESC 2022 that aimed to investigate […]
David Berg, ESC 2022: Antithrombotic therapy for patients in critical care with COVID-19, the COVID-PACT study
The COVID-PACT study focused on critically ill patients with coronavirus disease 2019 (COVID-19), assessing the use of antithrombotic therapy. In this touchCARDIO interview, we speak with Dr David Berg (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) to discuss the purpose and design of the COVID-19 study and how the outcomes will implicate […]
David Berg, ESC 2022: Unmet needs in the prevention of thrombotic events in patients with COVID-19
Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). Increased risk of thrombotic events is seen in patients infected with SARS-CoV-2, which is higher in patients needing critical care. In this touchCARDIO interview, we speak with Dr David Berg (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!